Clinical Trial Update: Study of the ICG Distribution in Breast Tumours or in Axillary Lymph Nodes of Patients After Neoadjuvant Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating how indocyanine green distributes within breast tumors and axillary lymph nodes after neoadjuvant therapy. The sponsor is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Jules Bordet Institute | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN